News
The FDA will begin promoting computer-based and lab-grown drug testing models to reduce the cost, time, and ethical burden of drug testing.
10don MSN
The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
Modeling and simulation will be a key component for shift to non-animal methodologies Introducing NAMVantage(TM), a flagship ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results